期刊文献+

复方甲氧那明联合孟鲁司特对感染后咳嗽的疗效观察 被引量:6

Clinical study of post infectionem cough treatment by Compound Methoxyphenamine Capsules combined with Montelukast
下载PDF
导出
摘要 目的观察复方甲氧那明联合孟鲁司特对感染后咳嗽的治疗效果。方法将90例患者分为3组:治疗组30例予复方甲氧那明胶囊及孟鲁司特片治疗;对照组30例使用强力枇杷露及阿奇霉素片治疗,观察治疗10 d后疗效,并与拒绝用药治疗的患者(模型组)比较。结果治疗后治疗组总有效率为93.3%,对照组总有效率为47.0%,模型组总有效率为23.3%,治疗组效果较模型组有明显改善(P<0.01),同时治疗组与对照组比较,疗效更明显(P<0.01)。结论复方甲氧那明联合孟鲁司特治疗感染后咳嗽,可明显控制临床症状且无明显的不良反应。 Objective To observe the clinical effect of Compound Methoxyphenamine Capsules combined with Montelukast on trentment of post infectionem cough.Methods 90 patients of post infectionem cough were divided into three groups at random: the observation group(n=30) was treated with Compound Methoxyphenamine Capsules combined with Montelukast;the control group(n=30) was treated with Azithromycin combined with Qiangli Pipa Lu,and then was observed the clinical effect after 10 days,and was compared with the model group(n=30) without treatment.Results The total effective rate of relieving cough was 93.3% in the observation group,47.0% in the control group,23.3% in the model group.The clinical effect of observation group was significantly better than that of model group(P〈0.01),and also significantly better than that of control group(P〈0.01).Conclusion Compound Methoxyphenamine Capsules combined with Montelukast can significantly control the clinical symptom of post infectionem cough and no significant adverse events were found.
出处 《临床肺科杂志》 2011年第11期1680-1681,共2页 Journal of Clinical Pulmonary Medicine
关键词 复方甲氧那明 孟鲁司特 感染后咳嗽 compound methoxyphenamine capsules montelukast post infectious cough
  • 相关文献

参考文献7

二级参考文献29

  • 1刘春丽,赖克方,钟南山.气道神经源性炎症与慢性咳嗽的发病机制[J].国外医学(呼吸系统分册),2004,24(4):237-239. 被引量:35
  • 2中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(草案)[J].中华结核和呼吸杂志,2005,28(11):738-744. 被引量:1455
  • 3赖克方,陈如冲,刘春丽,罗炜,钟淑卿,何梦章,李德容,钟南山.不明原因慢性咳嗽的病因分布及诊断程序的建立[J].中华结核和呼吸杂志,2006,29(2):96-99. 被引量:386
  • 4王晋舜.咳嗽变异性哮喘诊治探讨[J].临床肺科杂志,2006,11(3):369-369. 被引量:46
  • 5谈俊.复方甲氧那明治疗慢性咳嗽临床疗效观察[J].中国医学论坛报,2007年6月21日:B7.
  • 6Chung KF. Cytokines in chronic obstructive pulmonary disease [J]. Eur Respir J Suppl, 2001,34: 50s.
  • 7Peleman RA, Kips JC, Pauwels RA. Therapeutic activities of theophylline in chronic obstructive pulmonary disease [J]. Clin Exp Allergy, 1998, (Supp 3) :53.
  • 8Ito K, Lim S, Caramori G, et al. A molecular mechanism of action of theopylline: induction of histone deacetylase activity to decrease inflammatory gene expression [J]. Proc Natl Acad Sci USA, 2002,99(13):8921.
  • 9Yoshimura T. Modulation of cytokine production from human mononuclear cells by several agents [J]. Yakugaku Zassh,2000,120 (12): 1277.
  • 10Assanasen P, Naclerio RM. Antiallergic anti-inflammatory effects of H1antihistamines in humans [J]. Clin Allergic Immunol,2002,17:101.

共引文献1508

同被引文献32

  • 1赖克方.咳嗽严重度界定与咳嗽激发试验[J].中国实用内科杂志,2006,26(1):15-17. 被引量:95
  • 2李靖,罗炜,杨灵,罗锭芬,安嘉颖.急性上呼吸道感染后咳嗽的合理用药——附183例分析[J].新医学,2007,38(3):161-163. 被引量:41
  • 3许松云,田玉琴.药物所致尿潴留[J].中国误诊学杂志,2007,7(16):3933-3934. 被引量:2
  • 4.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.346-348.
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 6王晓平,王卫平.儿科学[M].7版.北京:人民卫生出版社,2008:261.35.
  • 7Arroll B. Antibiotics for upper respiratory tract infections:an o- verview of Cochrane reviews [ J ]. Respir Med, 2008,99 ( 3 ) : 255-261.
  • 8中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2009版)[J].中华结核和呼吸杂志,2009,3(2):407-413.
  • 9Ishida T, Yokoyama T, Iwasaku M, et al. Clinical investigation of postinfectious cough among adult patients with prolonged cough [J]. Nihon Kokyuki Gakkai Zasshi, 2010, 48: 179-185.
  • 10Braman SS. Postinfectious cough : ACCP evidence-based clinical practice guidelines[J]. Chest, 2006, 129(1 Suppl) : 138S-146S.

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部